parkinsonsdisease
Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. These findings, detailed in the journal Redox Biology, suggest a new frontier in the treatment of traumatic brain injuries and other neurodegenerative diseases. With the prevalence of neurological disorders r...
PsyPost (CA)
Recent scientific advancements have shown that a lesser-known compound from the cannabis plant, cannabinol (CBN), may hold promise for treating neurological disorders such as Alzheimer’s and Parkinson’s disease. Researchers at the Salk Institute discovered that not only does CBN protect brain cells from age-related damage, but its chemically modified versions could be even more effective. These findings, detailed in the journal Redox Biology, suggest a new frontier in the treatment of traumatic brain injuries and other neurodegenerative diseases. With the prevalence of neurological disorders r...
PsyPost (UK)
Researchers at Lund University in Sweden have successfully implanted 7 million lab-grown brain cells into a patient to treat Parkinson's disease. Swedish resident Thomas Matsson was the first in the world to test the method about a year ago. Matsson was diagnosed with Parkinson's when he was 42. For the last 17 years, he felt like he was walking through a syrup, he says. “‘Mister P,’ the disease, would pull my neck one way when I was going the other,” said Matsson. Today, Matsson recognises smells again and plays sports. “The syrup is gone. I’ve got my 7 million cells and they are starting to ...
Euronews (English)
Parkinson’s disease is a neurodegenerative movement disorder that progresses relentlessly00218-X). It gradually impairs a person’s ability to function until they ultimately become immobile and often develop dementia. In the U.S. alone, over a million people are afflicted with Parkinson’s, and new cases and overall numbers are steadily increasing. There is currently no treatment to slow or halt Parkinson’s disease. Available drugs don’t slow disease progression and can treat only certain symptoms. Medications that work early in the disease, however, such as Levodopa, generally become ineffectiv...
PsyPost (UK)
Parkinson’s disease is a neurodegenerative movement disorder that progresses relentlessly00218-X). It gradually impairs a person’s ability to function until they ultimately become immobile and often develop dementia. In the U.S. alone, over a million people are afflicted with Parkinson’s, and new cases and overall numbers are steadily increasing. There is currently no treatment to slow or halt Parkinson’s disease. Available drugs don’t slow disease progression and can treat only certain symptoms. Medications that work early in the disease, however, such as Levodopa, generally become ineffectiv...
PsyPost (CA)
Parkinson’s disease is a neurodegenerative movement disorder that progresses relentlessly00218-X). It gradually impairs a person’s ability to function until they ultimately become immobile and often develop dementia. In the U.S. alone, over a million people are afflicted with Parkinson’s, and new cases and overall numbers are steadily increasing. There is currently no treatment to slow or halt Parkinson’s disease. Available drugs don’t slow disease progression and can treat only certain symptoms. Medications that work early in the disease, however, such as Levodopa, generally become ineffectiv...
PsyPost
A special samba drum class has been a refuge for Parkinson’s disease patients in Wales where they can move and socialise. Now researchers in neurogenerative diseases are planning a study to see if samba really can help ease people’s symptoms. Parkinson's disease is a degenerative disease caused by a loss of nerve cells. Due to a loss of the chemical dopamine, it affects body movement as well as mental health, according to the World Health Organization (WHO). Parkinson’s patients experience problems with balance, standing, and walking and sudden rigidity as well as cognitive decline from dement...
Euronews (English)
Scientists have made a significant leap in understanding how our brains process social interactions, specifically focusing on the roles of dopamine and serotonin, two critical chemical messengers in the brain. The study, led by Virginia Tech neuroscientists and published in Nature Human Behavior, involved Parkinson’s disease patients who were undergoing brain surgery while awake. These patients participated in a game that tested their responses to financial offers from both humans and computers, revealing fascinating insights into the neurochemical underpinnings of social decision-making. Back...
PsyPost (UK)
Scientists have made a significant leap in understanding how our brains process social interactions, specifically focusing on the roles of dopamine and serotonin, two critical chemical messengers in the brain. The study, led by Virginia Tech neuroscientists and published in Nature Human Behavior, involved Parkinson’s disease patients who were undergoing brain surgery while awake. These patients participated in a game that tested their responses to financial offers from both humans and computers, revealing fascinating insights into the neurochemical underpinnings of social decision-making. Back...
PsyPost
Scientists have made a significant leap in understanding how our brains process social interactions, specifically focusing on the roles of dopamine and serotonin, two critical chemical messengers in the brain. The study, led by Virginia Tech neuroscientists and published in Nature Human Behavior, involved Parkinson’s disease patients who were undergoing brain surgery while awake. These patients participated in a game that tested their responses to financial offers from both humans and computers, revealing fascinating insights into the neurochemical underpinnings of social decision-making. Back...
PsyPost (CA)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら